4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 13,612 | 6,986 | 0 | 0 | 0 |
| Gross Profit | 13,612 | 6,986 | N/A | N/A | N/A |
| Operating Expenses | 70,276 | 57,750 | 0 | 0 | 0 |
| Operating Income | -56,664 | -50,764 | N/A | N/A | N/A |
| Other Income | -29 | 1,458 | 0 | 0 | 0 |
| Pre-tax Income | -56,693 | -49,306 | 0 | 0 | 0 |
| Net Income Continuous | -56,693 | -49,306 | N/A | N/A | N/A |
| Net Income | $-56,693 | $-49,306 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -8.82 | -9.59 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -8.82 | -9.59 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -8.82 | -9.59 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -8.82 | -9.59 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -8.82 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-55,221 | $-49,760 | $N/A | $N/A | $N/A |